Patents by Inventor Peter Preiser

Peter Preiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AN APPARATUS FOR A CELLULOSE-BASED VERTICAL FLOW ASSAY AND RELATED METHOD
    Publication number: 20240286127
    Abstract: There is provided an apparatus for a cellulose-based vertical flow assay, the apparatus comprising: a holder for supporting a cellulose substrate having a plurality of test zones thereon, the holder having a base plate and engaging members; and a lid for reversibly engaging with the engaging members of the holder such that when engaged, the lid is disposed over the base plate and a gap exists between the lid and the base plate, wherein the lid comprises a plurality of openings for allowing access to the test zones on the cellulose substrate. Also provided are related methods.
    Type: Application
    Filed: August 15, 2022
    Publication date: August 29, 2024
    Inventors: Sing Mei Lim, Hoi Lok Cheng, Patthara Kongsuphol, Huan Jia, Say Yong Ng, Hadley Sikes Johnson, Peter Preiser, Megan Earley McBee
  • Binding domain of reticulocyte binding proteins
    Patent number: 8252293
    Abstract: The present invention provides isolated polynucleotides, polypeptides, antibodies and/or vaccines for the prevention and/or treatment of malaria caused by Plasmodium falciparum and/or Plasmodium vivax. In particular, the polypeptide fragments are derived from the binding domain of the reticulocyte binding proteins of Plasmodium falciparum and/or Plasmodium vivax. The present invention also provides recombinant vaccines and their use in the prevention and/or treatment of malaria.
    Type: Grant
    Filed: September 13, 2007
    Date of Patent: August 28, 2012
    Assignee: Nanyang Technological University
    Inventors: Xiaohong Gao, Peter Preiser
  • BINDING DOMAIN OF PLASMODIUM RETICULOCYTE BINDING PROTEINS
    Publication number: 20100297131
    Abstract: The present invention provides isolated polynucleotides, polypeptides, antibodies and/or vaccines for the prevention and/or treatment of malaria caused by Plasmodium falciparum and/or Plasmodium vivax. In particular, the polypeptide fragments are derived from the binding domain of the reticulocyte binding proteins of Plasmodium falciparum and/or Plasmodium vivax. The present invention also provides recombinant vaccines and their use in the prevention and/or treatment of malaria.
    Type: Application
    Filed: September 13, 2007
    Publication date: November 25, 2010
    Inventors: Xiaohong Goa, Peter Preiser
  • EF-Tu protein encoded on the plastid DNA of the malaria parasite and protein synthesis inhibitors effective as anti-malarial compounds
    Publication number: 20020058266
    Abstract: The plastid DNA of the malaria parasite Plasmodium falciparum has been sequenced and found to contain a gene encoding an EF-Tu protein. Inhibitors of the protein are effective as anti-malarial compounds and the protein can be used to screen for such inhibitors. Furthermore, the 23S ribosomal RNA encoded on the malaria parasite plastid DNA is a target for anti-malarial compounds and the antibiotic thiostrepton acts as an anti-malarial by binding to the RNA.
    Type: Application
    Filed: May 1, 2001
    Publication date: May 16, 2002
    Applicant: MEDICAL RESEARCH COUNCIL
    Inventors: Barbara Clough, Peter Preiser, Robert John Macleod Wilson
  • Method of screening for anti-malarial compounds
    Patent number: 6268160
    Abstract: The plastid DNA of the malaria parasite Plasmodium falciparum has been sequenced and found to contain a gene encoding an EF-Tu protein. Inhibitors of the protein are effective as anti-malarial compounds and the protein can be used to screen for such inhibitors. Furthermore, the 23S ribosomal RNA encoded on the malaria parasite plastid DNA is a target for anti-malarial compounds and the antibiotic thiostrepton acts as an anti-malarial by binding to the RNA.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: July 31, 2001
    Assignee: Medical Research Council
    Inventors: Barbara Clough, Peter Preiser, Robert John Macleod Wilson